Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Feb;40(2):398-403.
doi: 10.1111/jgh.16842. Epub 2024 Dec 4.

Tranexamic Acid With Acid Suppression Versus Acid Suppression Alone as Therapy for Upper Gastrointestinal Bleeding: A Meta-Analysis of Randomized Controlled Trials

Affiliations
Meta-Analysis

Tranexamic Acid With Acid Suppression Versus Acid Suppression Alone as Therapy for Upper Gastrointestinal Bleeding: A Meta-Analysis of Randomized Controlled Trials

Sheau-Wen Kan et al. J Gastroenterol Hepatol. 2025 Feb.

Abstract

Background: Studies have reported the benefits of tranexamic acid (TXA) in controlling bleeding across various conditions. However, the effect of TXA in upper gastrointestinal bleeding (UGIB) remains controversial, and its therapeutic impact when combined with acid suppression, particularly proton pump inhibitors (PPIs), which are considered first-line therapy for bleeding peptic ulcers, has not been reported.

Methods: We systematically searched PubMed, Embase, and Google Scholar from January 1987 to June 2024 using predefined keywords to identify RCTs meeting our inclusion criteria, including details of TXA dosage, route of administration, and choice of acid suppressants. Data from selected trials were extracted, and a meta-analysis was performed using random-effects modeling.

Results: Six trials with 709 participants were included. Baseline patient characteristics in the selected trials were balanced. The rebleeding rate, mortality, need for blood transfusion, units of blood transfused, and need for salvage therapy were compared. The TXA with acid suppression group significantly reduced the risk of rebleeding (RR: 0.63, 95% CI: 0.41-0.96), units of blood transfused (mean difference: -1.08, 95% CI: -1.44 to -0.71), and the need for salvage therapy (RR: 0.28, 95% CI: 0.12-0.64). No significant difference was observed in mortality rate (RR: 0.74) and need for blood transfusion (RR: 1.01) between the two groups, but outcomes favored the TXA and acid suppression group.

Conclusions: We suggest combining TXA with acid suppression as a first-line therapy for UGIB patients. Further trials should be conducted to determine the optimal dose and route of TXA administration for better care.

Keywords: meta‐analysis; mortality; randomized controlled trials; rebleeding; upper gastrointestinal bleeding.

PubMed Disclaimer

References

    1. D. K. Li, L. Laine, and D. L. Shung, “Trends in Upper Gastrointestinal Bleeding in Patients on Primary Prevention Aspirin: A Nationwide Emergency Department Sample Analysis, 2016–2020,” American Journal of Medicine 136, no. 12 (2023): 1179–1186.e1.
    1. C. Antunes, C. Tian, and E. L. Copelin II, “Upper Gastrointestinal Bleeding,” in StatPearls (Treasure Island, FL: StatPearls Publishing, 2024).
    1. S. J. Rosenstock, M. H. Møller, H. Larsson, et al., “Improving Quality of Care in Peptic Ulcer Bleeding: Nationwide Cohort Study of 13,498 Consecutive Patients in the Danish Clinical Register of Emergency,” Surgery 108, no. 9 (2013): 1449–1457.
    1. J. Cai, J. Ribkoff, S. Olson, et al., “The Many Roles of Tranexamic Acid: An Overview of the Clinical Indications for TXA in Medical and Surgical Patients,” European Journal of Hematology 104, no. 2 (2020): 79–87.
    1. O. O'Donnell, C. Gallagher, M. G. Davey, J. Coulter, and M. Regan, “A Systematic Review and Meta‐Analysis Assessing the Use of Tranexamic Acid (TXA) in Acute Gastrointestinal Bleeding,” Irish Journal of Medical Science (1971 ‐) 193, no. 2 (2024): 705–719.

Publication types

MeSH terms

LinkOut - more resources